Atorvastatin
Lipitor
HMG-CoA Reductase Inhibitor
NADAC/unit
$0.0252
No Shortage
Tier 1: 297.9%
22 Manufacturers
96 ANDAs
Atorvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.
vs. brand Lipitor: Generic saves up to 100% per unit
Market Intelligence
2025-10-22 Class II Recall: Ascend Laboratories, LLC
2025-10-22 Class II Recall: Ascend Laboratories, LLC
2025-10-22 Class II Recall: Ascend Laboratories, LLC
2025-10-22 Class II Recall: Ascend Laboratories, LLC
2025-04-09 Class II Recall: BIOCON PHARMA INC
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAPOTEX INCAUROBINDO PHARMA LTDBIOCON PHARMA LTDCHARTWELL RX SCIENCES LLCCMP DEVELOPMENT LLCDR REDDYS LABORATORIES LTDGRAVITI PHARMACEUTICALS PRIVATE LTDHETERO LABS LTD UNIT VLANNETT CO INCLAURUS LABS LTDMACLEODS PHARMACEUTICALS LTDMANKIND PHARMA LTDMICRO LABS LTD INDIAMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCSCIEGEN PHARMACEUTICALS INCSHANDONG XINHUA PHARMACEUTICAL CO LTDTEVA PHARMACEUTICALS INCTEVA PHARMACEUTICALS USAUMEDICA LABORATORIES PRIVATE LTDUPJOHN MANUFACTURING IRELAND UNLTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.